Inflammatory storm and metabolic disorders: unraveling heterogeneity in mortality risk for comorbid diabetes mellitus and heart failure via the C-reactive protein-triglyceride-glucose index
This study demonstrates the clinical utility of the novel inflammatory-metabolic index CTI in mortality risk assessment for ADHF patients, with superior risk stratification efficacy observed in those with DM comorbidity.
Authors
- Tongqing Liao
- Zhiyu Xiong
- Guotai Sheng (ORCID: https://orcid.org/0000-0001-5298-4724)
- Guobo Xie (ORCID: https://orcid.org/0000-0002-5020-4920)
- Yang Zou (ORCID: https://orcid.org/0000-0002-9373-928X)
- Shiming He
- Hongyi Yang (ORCID: https://orcid.org/0000-0003-2908-5346)
- Qun Wang (ORCID: https://orcid.org/0000-0003-4853-1727)
- Na Zhang (ORCID: https://orcid.org/0000-0002-5706-641X)
- Wei Wang (ORCID: https://orcid.org/0000-0003-1005-059X)
- Shuhua Zhang (ORCID: https://orcid.org/0000-0002-0065-1618)
- Lin Xie (ORCID: https://orcid.org/0000-0001-5385-7380)
- Hengcheng Lu (ORCID: https://orcid.org/0009-0003-5110-0829)
Institutions
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-11-19
- DOI
- https://doi.org/10.3389/fendo.2025.1689238
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Strong
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province